4:持股變動聲明-董事 Aryeh Jason
05/03 06:10
4:持股變動聲明-董事 KOZARICH JOHN W
04/27 06:39
Ligand Pharmaceuticals | 4:持股變動聲明-高管 Davis Todd C
03/28 05:50
Ligand Pharmaceuticals | 4:持股變動聲明-董事 Sabba Stephen L
03/08 02:30
Ligand Pharmaceuticals | 4:持股變動聲明-董事 Aryeh Jason
03/07 06:31
Ligand Pharmaceuticals | 4:持股變動聲明-高管 Reardon Andrew
03/01 07:54
Ligand Pharmaceuticals | 4:持股變動聲明-高管 Korenberg Matthew E
03/01 07:54
Ligand Pharmaceuticals | 4:持股變動聲明-高管 Espinoza Octavio
03/01 07:54
Ligand Pharmaceuticals | 4:持股變動聲明-高管 Davis Todd C
03/01 07:54
Ligand Pharmaceuticals | 4:持股變動聲明-高管 Reardon Andrew
02/17 09:12
Ligand Pharmaceuticals | 4:持股變動聲明-高管 Korenberg Matthew E
02/17 09:12
Ligand Pharmaceuticals | 4:持股變動聲明-高管 Espinoza Octavio
02/17 09:12
Ligand Pharmaceuticals | 4:持股變動聲明-高管 Davis Todd C
02/17 09:12
Ligand Pharmaceuticals | SC 13G:超過5%持股股東披露文件-Macquarie Group Limited(5.66%),Macquarie Management Holdings Inc(5.66%)等
02/14 19:31
Ligand Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-The Vanguard Group(10.76%)
02/14 06:50
Ligand Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-Janus Henderson Group plc(7.7%),Janus Henderson Triton Fund(5.1%)
02/14 04:41
Ligand Pharmaceuticals | SC 13G:超過5%持股股東披露文件-THE GOLDMAN SACHS GROUP, INC.(6.8 %),GOLDMAN SACHS & CO. LLC(6.8 %)
02/13 08:45
Ligand Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-BlackRock, Inc.(17.0%)
01/22 13:00
Ligand Pharmaceuticals | 4:持股變動聲明-高管 Reardon Andrew
01/04 13:00
Ligand Pharmaceuticals | 4:持股變動聲明-首席財務官 Espinoza Octavio
2023/12/07 04:27
暫無數據
暫無數據